» Articles » PMID: 35992496

SMRI: A New Method for SiRNA Design for COVID-19 Therapy

Overview
Publisher Science Press
Date 2022 Aug 22
PMID 35992496
Authors
Affiliations
Soon will be listed here.
Abstract

Supplementary Information: The online version contains supplementary material available at 10.1007/s11390-021-0826-x.

References
1.
Schubert S, Grunweller A, Erdmann V, Kurreck J . Local RNA target structure influences siRNA efficacy: systematic analysis of intentionally designed binding regions. J Mol Biol. 2005; 348(4):883-93. DOI: 10.1016/j.jmb.2005.03.011. View

2.
Vance V, Vaucheret H . RNA silencing in plants--defense and counterdefense. Science. 2001; 292(5525):2277-80. DOI: 10.1126/science.1061334. View

3.
Hsieh A, Bo R, Manola J, Vazquez F, Bare O, Khvorova A . A library of siRNA duplexes targeting the phosphoinositide 3-kinase pathway: determinants of gene silencing for use in cell-based screens. Nucleic Acids Res. 2004; 32(3):893-901. PMC: 373385. DOI: 10.1093/nar/gkh238. View

4.
Preall J, Sontheimer E . RNAi: RISC gets loaded. Cell. 2005; 123(4):543-5. DOI: 10.1016/j.cell.2005.11.006. View

5.
Amarzguioui M, Prydz H . An algorithm for selection of functional siRNA sequences. Biochem Biophys Res Commun. 2004; 316(4):1050-8. DOI: 10.1016/j.bbrc.2004.02.157. View